What Medications Should You Not Take With Melatonin?
What Medications Should You Not Take With Melatonin?
Melatonin is one of the most popular sleep supplements in North America, with over 3 million Americans taking it on any given night. But because it's sold over the counter, many users don't know that melatonin can interact meaningfully with more than 300 medications — from common blood thinners to antidepressants to diabetes drugs. This guide covers every major interaction category, what the evidence actually says about each, and what to do if you're already on prescription medications and considering melatonin.
Key Takeaways
- Melatonin is metabolized by liver enzymes CYP1A2 and CYP2C19 — medications that inhibit these enzymes can increase melatonin blood levels dramatically, raising the risk of excessive sedation.
- Blood thinners such as warfarin carry a documented interaction risk — a placebo-controlled study found 3mg oral melatonin reduced two key clotting factors within 60 minutes of ingestion.
- Fluvoxamine (Luvox), used for OCD and depression, is one of the most potent CYP1A2 inhibitors and can dramatically elevate melatonin plasma levels, causing excessive drowsiness.
- Immunosuppressants (cyclosporine, tacrolimus) used after organ transplants may be less effective when combined with melatonin, according to Mayo Clinic guidance on melatonin interactions.
- A 2017 NIH-cited study of 31 melatonin supplements found most products didn't match their label dose — making accurate dosing especially important for people on interacting medications.
Table of Contents
- How Melatonin Is Metabolized — and Why It Matters for Drug Interactions
- Blood Thinners and Anticoagulants
- Antidepressants, Fluvoxamine, and CYP1A2 Inhibitors
- Sedatives, Sleep Medications, and CNS Depressants
- Blood Pressure Medications
- Diabetes Medications
- Immunosuppressants and Seizure Medications
- Other Notable Interactions: Contraceptives, Antibiotics, Caffeine
- Why Starting Dose Matters When You're on Other Medications
- Frequently Asked Questions
1. How Melatonin Is Metabolized — and Why It Matters for Drug Interactions
When you swallow a melatonin supplement, it travels to your liver before entering your bloodstream. There, approximately 90% of melatonin is broken down by the CYP1A2 enzyme, with a smaller contribution from CYP2C19. This first-pass metabolism is the primary reason melatonin blood levels can vary so widely from person to person — and why drug interactions occur.
Many common prescription medications either inhibit or induce CYP1A2. When a CYP1A2 inhibitor is present, the liver processes melatonin more slowly — pushing blood levels higher than intended and prolonging its effects. When a CYP1A2 inducer is present (like phenobarbital), melatonin is cleared faster, potentially reducing its effectiveness. Research confirms that CYP2C19 substrates such as omeprazole and citalopram also increase melatonin metabolite excretion, meaning these drugs, too, alter how melatonin behaves in your body.
The practical consequence: the dose printed on your melatonin bottle is not the dose you'll actually experience if you're on interacting medications. A 1mg dose might behave like 5mg or more in someone taking fluvoxamine, for example. This is why interaction awareness matters even when melatonin is labelled as "natural" — its pharmacokinetics are genuinely altered by a wide range of drugs.
2. Blood Thinners and Anticoagulants
The interaction between melatonin and blood-thinning medications is among the most clinically documented. A randomized, placebo-controlled study published in the Journal of Pineal Research found that a single 3mg oral dose of melatonin significantly reduced two key clotting factors — FVIII:C and fibrinogen — within 60 minutes in healthy young men. Researchers also observed a possible dose-response relationship, meaning higher melatonin concentrations predicted greater reductions in clotting activity.
The clinical concern is additive bleeding risk when melatonin is combined with anticoagulants. A case series of 10 patients at Massachusetts General Hospital who received both melatonin and warfarin found that 8 of 10 had possible or probable drug interactions, with measurable changes in INR and prothrombin time in all patients. Anticoagulants with documented melatonin interaction risk include warfarin (Coumadin), aspirin (at antiplatelet doses), clopidogrel (Plavix), apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), and enoxaparin (Lovenox).
The guidance from multiple clinical sources is consistent: if you are on any blood thinner, consult your prescriber before starting melatonin. This is especially important before surgery, when bleeding risk is already elevated. Regular INR monitoring is recommended for warfarin users who do use melatonin concurrently.
3. Antidepressants, Fluvoxamine, and CYP1A2 Inhibitors
Among all melatonin-drug interactions, the one with fluvoxamine (Luvox) is the most pharmacologically significant. Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) used primarily for obsessive-compulsive disorder. It is also one of the most potent inhibitors of CYP1A2 in clinical use. Research has shown that fluvoxamine substantially increases serum melatonin concentrations — the mechanism is decreased hepatic metabolism of melatonin via CYP1A2 and CYP2C19 inhibition. This can produce levels many times higher than a supplement dose alone, leading to excessive and prolonged sedation.
Other antidepressants carry a more moderate interaction risk. Citalopram, nortriptyline, and certain tricyclic antidepressants also inhibit CYP2C19 to varying degrees and may elevate melatonin metabolite levels. A case of severe sedation was reported in a patient taking oxycodone, citalopram, and nortriptyline who commenced melatonin — illustrating how compounding interactions can occur in polypharmacy situations. SSRIs as a class are commonly prescribed, and are used by an estimated 20% of older patients in residential care facilities.
Monoamine oxidase inhibitors (MAOIs) also present a concern when combined with melatonin, given overlapping mechanisms affecting neurotransmitter activity. If you take any antidepressant — particularly fluvoxamine, an SSRI, or a tricyclic — raise this with your prescriber before using melatonin. In some cases, a markedly lower starting dose (0.3mg rather than 1–3mg) may be appropriate given the altered pharmacokinetics.
4. Sedatives, Sleep Medications, and CNS Depressants
Melatonin has its own sedating effect, and when combined with other central nervous system (CNS) depressants, that effect compounds. StatPearls clinical guidance is explicit: melatonin should not be combined with benzodiazepines, zolpidem (Ambien), or eszopiclone (Lunesta) due to the risk of excessive sedation. This category includes a wide range of commonly prescribed and over-the-counter medications: diazepam (Valium), lorazepam (Ativan), clonazepam (Klonopin), alprazolam (Xanax), and zaleplon (Sonata).
The real-world risk of this combination is not theoretical. A study in middle-older aged adults found that melatonin potentiated the effect of zolpidem in impairing psychomotor function and driving performance. Older adults are particularly vulnerable to this interaction, as both melatonin clearance and CNS resilience decline with age. Falls, impaired judgment, and next-day cognitive impairment are practical risks of over-sedation in this population.
Opioid pain medications, antihistamines (diphenhydramine/Benadryl), certain antipsychotics, and alcohol all fall into this category as well. At the more severe end, Medscape's clinical database flags sodium oxybate (GHB) as an "avoid or use alternate drug" combination with melatonin due to the risk of profound sedation and respiratory depression. The general guidance: do not combine melatonin with any sedating substance without explicit discussion with your physician or pharmacist.
5. Blood Pressure Medications
The relationship between melatonin and blood pressure medications is bidirectional and somewhat counterintuitive. Melatonin has been shown in multiple studies to modestly lower nighttime blood pressure — by approximately 3–5 mmHg in some protocols — which can be additive with antihypertensive medications, potentially causing hypotension (excessively low blood pressure). Symptoms of excessive blood pressure reduction include dizziness, weakness, and fainting, and older adults are particularly susceptible.
One specific interaction warrants particular attention. A clinical study found that melatonin competed with nifedipine at the calcium channel receptor, effectively reducing the drug's activity and raising blood pressure in those individuals. This is the opposite of the additive-lowering effect seen with most antihypertensives — the interaction with calcium-channel blockers may actually reduce medication effectiveness rather than enhance it. Nifedipine is used for both hypertension and angina.
If you take any antihypertensive medication — including ACE inhibitors, ARBs, beta-blockers, calcium-channel blockers, or diuretics — Mayo Clinic advises that melatonin might worsen blood pressure control. Home blood pressure monitoring for 1–2 weeks after starting melatonin is a reasonable precaution for anyone on antihypertensives, and your prescriber should be informed.
6. Diabetes Medications
Melatonin affects glucose metabolism, though the direction of that effect varies between individuals and study designs. The core concern for people on diabetes medications is hypoglycemia — blood sugar that drops too low, particularly during sleep when symptoms go unnoticed. A 12-week study in obese individuals found that 3mg/day of melatonin significantly reduced both glucose and insulin levels (p<0.05), suggesting a blood-glucose-lowering effect that could compound the action of insulin or oral hypoglycemic agents like metformin, glipizide, or glyburide.
The evidence is not entirely consistent, however. A 2022 review of research on melatonin and glucose metabolism reported mixed results — some studies found blood-sugar-lowering effects, others found no significant change, and the effect appears to depend on timing, formulation, and individual genetics (particularly MTNR1b receptor variants). Some earlier small studies found melatonin impaired glucose tolerance, adding further uncertainty.
What this means practically: if you take insulin or any oral diabetes medication, the unpredictability of this interaction makes monitoring essential. Keep glucose tablets or gel accessible when starting melatonin. Starting at a very low dose (0.3mg) and monitoring blood glucose closely for the first 1–2 weeks is the prudent approach. This is not a combination to begin without informing your endocrinologist or diabetes care team.
7. Immunosuppressants and Seizure Medications
Two medication categories carry the most serious melatonin interaction risk: immunosuppressants and anticonvulsants. Melatonin has immunostimulatory properties — it can activate certain immune responses and increase cytokine production. This directly opposes the purpose of immunosuppressant medications such as cyclosporine and tacrolimus, which are used after organ transplants to prevent rejection, and corticosteroids like prednisone, used for autoimmune conditions. Mayo Clinic explicitly identifies immunosuppressants as a category where melatonin can stimulate immune function and interfere with therapy. For transplant recipients, reducing immunosuppressant effectiveness is not a minor concern — it carries life-threatening implications.
Anticonvulsant medications present a dual concern. Melatonin might inhibit the effects of anticonvulsants and increase the frequency of seizures, particularly in children with neurological disabilities, according to Mayo Clinic. Simultaneously, several anticonvulsants — including phenobarbital and primidone — are potent CYP1A2 inducers, meaning they increase the rate at which melatonin is cleared from the body, potentially reducing its effectiveness as a sleep aid. Carbamazepine and phenytoin have similar enzyme-inducing properties.
The guidance for both categories is unambiguous: do not start melatonin without explicit approval from your specialist if you are on immunosuppressants or seizure medications. These are not categories where a pharmacist consultation alone is sufficient — the prescribing physician managing your underlying condition needs to be involved in the decision.
8. Other Notable Interactions: Contraceptives, Antibiotics, Caffeine
Oral contraceptives can raise melatonin blood levels. Estrogen inhibits melatonin metabolism, meaning women on hormonal birth control may experience higher circulating melatonin than expected from a given dose. GoodRx clinical pharmacists note that this interaction can cause increased drowsiness and other melatonin side effects in women on oral contraceptives, and suggest starting at a lower dose (0.3–0.5mg rather than 1–3mg) when this combination is used.
Certain antibiotics — particularly fluoroquinolones (ciprofloxacin, levofloxacin) and erythromycin — inhibit CYP1A2 metabolism of melatonin, potentially raising its blood levels during the course of treatment. This interaction is generally considered low-risk given the short duration of most antibiotic courses, but it is worth knowing if you experience unusual drowsiness while taking an antibiotic and melatonin together. The interaction resolves when the antibiotic is discontinued.
Caffeine competes with melatonin at the CYP1A2 enzyme. One study found that concurrent administration of caffeine increased maximum melatonin concentrations by 42% in younger adults, via inhibition of first-pass CYP1A2 metabolism. The practical implication is not to take melatonin close to caffeinated beverages — both because caffeine delays sleep onset on its own, and because it may elevate your effective melatonin dose unpredictably.
9. Why Starting Dose Matters When You're on Other Medications
One of the most consistent themes across the interaction evidence is that most risks increase with dose. The majority of concerning melatonin interactions — with blood thinners, sedatives, antidepressants — become more significant as the absolute amount of melatonin in the bloodstream rises. Yet melatonin supplements in North America typically start at 1mg, with many products ranging from 5mg to 10mg. The NIH notes that a 2017 study of 31 melatonin supplements found that most products did not match their stated dose, and 26% contained serotonin as an unlabelled ingredient — adding another layer of uncertainty for medication users.
Pharmacologists and sleep clinicians consistently recommend that adults — particularly those on any interacting medication — start at the lowest effective dose: 0.3mg to 0.5mg, not the 1–5mg shown on most supplement labels. This recommendation comes in part from the fact that endogenous nocturnal melatonin peaks at only 0.1–0.3mg equivalent blood levels. Large supplement doses exceed physiological levels substantially and increase the magnitude of any pharmacokinetic interaction.
BioAbsorb Liposomal Liquid Melatonin uses a graduated dropper that allows dosing in approximately 0.25mg increments — a meaningful practical advantage for anyone on interacting medications who needs to start low and titrate slowly. The liposomal delivery system also provides consistent absorption, which matters when you're trying to predict how melatonin will interact with your medication regimen. Always confirm any dose adjustment with your prescriber or pharmacist before making changes.
Frequently Asked Questions
Can I take melatonin with my antidepressant?
It depends on which antidepressant. The highest-risk combination is melatonin with fluvoxamine (Luvox), which potently inhibits CYP1A2 and can dramatically elevate melatonin blood levels, causing excessive sedation. Other SSRIs (sertraline, escitalopram) carry lower interaction risk, though elevated melatonin levels are still possible. MAOIs should generally not be combined with melatonin without specialist oversight. Tell your prescriber which antidepressant you're on — they can assess the specific interaction risk for your medication.
Is melatonin safe if I take blood pressure medication?
Melatonin can interact with blood pressure medications in two directions: it may lower blood pressure in an additive way with most antihypertensives, potentially causing dizziness or hypotension; or it may reduce the effectiveness of calcium-channel blockers like nifedipine. Mayo Clinic advises caution for anyone on blood pressure medications. If you do start melatonin, monitor your blood pressure at home for the first 1–2 weeks and report any significant changes to your prescriber.
What happens if you take melatonin with a sleeping pill?
Combining melatonin with prescription sleep aids like zolpidem, eszopiclone, or benzodiazepines can cause additive sedation — more drowsiness, impaired coordination, and slower reaction times than either substance alone. A study confirmed that melatonin potentiated zolpidem's impairment of psychomotor function and driving skills in older adults. If you're transitioning from a prescription sleep medication to melatonin, discuss a tapering plan with your doctor rather than taking both together.
Can people with diabetes take melatonin?
Possibly, but with careful monitoring. Melatonin can lower blood glucose in some individuals, which risks hypoglycemia when combined with insulin or oral hypoglycemic medications. The effect is not consistent across individuals and depends on genetics, timing, and formulation. Starting at a low dose (0.3mg), monitoring glucose closely for 1–2 weeks, and keeping fast-acting glucose on hand are appropriate precautions. Inform your diabetes care team before starting — do not self-manage this combination.
Are there medications that make melatonin work better or worse?
Yes — both directions are documented. CYP1A2 inhibitors (fluvoxamine, certain antibiotics, oral contraceptives, caffeine) slow melatonin clearance and increase its effective blood level, making a given dose "stronger." CYP1A2 inducers (phenobarbital, carbamazepine, smoking) speed melatonin clearance, making a given dose less effective. StatPearls confirms that drugs interacting with CYP1A2 are likely to significantly slow down melatonin metabolism — meaning your pharmacist is the right person to run a full interaction check before you start.
Should I tell my doctor before taking melatonin?
If you take any prescription medication, yes. Melatonin's over-the-counter status leads many people to treat it as categorically different from drugs — but its pharmacology intersects meaningfully with anticoagulants, antidepressants, antihypertensives, diabetes medications, immunosuppressants, anticonvulsants, and sedatives. Your doctor and pharmacist can run a drug interaction check against your full medication list in minutes — a step that takes significantly less time than managing an adverse event after the fact.
Conclusion
Melatonin interacts with a wider range of medications than most users realize, spanning blood thinners, antidepressants, sedatives, blood pressure drugs, diabetes medications, immunosuppressants, and seizure medications. The interactions range from clinically manageable (with monitoring) to genuinely serious (immunosuppressants for transplant recipients, anticonvulsants in children with neurological disorders). The NIH is clear that "natural" does not mean "without interactions" — and a pharmacist interaction check before starting is the single most practical step any medication user can take. If you do decide melatonin is appropriate for your situation, start at the lowest dose possible and discuss it with your prescriber.
Research References
- Oral melatonin reduces blood coagulation activity: a placebo-controlled study in healthy young men. Journal of Pineal Research, Vol. 44 (2008). Found that a single 3mg dose of oral melatonin significantly reduced procoagulant factors FVIII:C and fibrinogen within 60 minutes, with a possible dose-response relationship between melatonin concentration and reduced clotting activity.
- Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes. European Journal of Clinical Pharmacology (2001). Identified CYP1A2 as the primary enzyme in melatonin's 6-hydroxylation pathway and confirmed that CYP1A2-inhibiting drugs such as fluvoxamine have significant potential to interact with melatonin at pharmacologically relevant concentrations.
- Potential drug interactions with melatonin. Pharmacological Research (2014). In vitro study using human liver preparations confirmed that CYP1A2 inhibitors impair melatonin metabolism and that caffeine more than doubled melatonin plasma levels via the same pathway; CYP2C19 substrates also altered melatonin's metabolite excretion.
- Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. Clinical Interventions in Aging (2023). Systematic review confirming that melatonin potentiates zolpidem-induced psychomotor impairment, that caffeine increases melatonin concentration by 42%, and that fluvoxamine substantially elevates serum melatonin — with these antidepressants used by 20% of older nursing home residents.
- Evaluation of the Potential Drug Interaction of Melatonin and Warfarin: A Case Series. Life Science Journal, Vol. 13 (2016). Case series of 10 patients at Massachusetts General Hospital found that 8 of 10 had possible or probable drug interactions when taking both warfarin and melatonin, with changes in INR and prothrombin time observed across the cohort.
- Melatonin — StatPearls. National Center for Biotechnology Information / NIH (updated 2024). Clinical reference confirming CYP1A2-based metabolism, interaction risk with benzodiazepines and z-drugs, and fluvoxamine as the highest-risk antidepressant combination.
- Melatonin: What You Need to Know. National Center for Complementary and Integrative Health, NIH (2022). Government overview confirming melatonin's dietary supplement regulatory status in the US, noting that a 2017 study of 31 supplement products found most did not match stated doses and 26% contained unlabelled serotonin.
- Melatonin. Mayo Clinic Drug and Supplement reference. Comprehensive institutional summary listing 8 primary drug interaction categories: anticoagulants, anticonvulsants, blood pressure drugs, CNS depressants, diabetes medications, contraceptives, CYP enzyme substrates, and immunosuppressants.
About the Author
David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.
Important Disclaimers
Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.
FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.